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Anti‑staphylococcal activity 
and mode of action of thioridazine 
photoproducts
Tatiana Tozar1*, Sofia Santos Costa2, Ana‑Maria Udrea1,3, Viorel Nastasa1,4, Isabel Couto2, 
Miguel Viveiros2, Mihail Lucian Pascu1,5* & Mihaela Oana Romanitan6
Antibiotic resistance became an increasing risk for population health threatening our ability to 
fight infectious diseases. The objective of this study was to evaluate the activity of laser irradiated 
thioridazine (TZ) against clinically‑relevant bacteria in view to fight antibiotic resistance. TZ in 
ultrapure water solutions was irradiated (1–240 min) with 266 nm pulsed laser radiation. Irradiated 
solutions were characterized by UV–Vis and FTIR absorption spectroscopy, thin layer chromatography, 
laser‑induced fluorescence, and dynamic surface tension measurements. Molecular docking studies 
were made to evaluate the molecular mechanisms of photoproducts action against Staphylococcus 
aureus and MRSA. More general, solutions were evaluated for their antimicrobial and efflux inhibitory 
activity against a panel of bacteria of clinical relevance. We observed an enhanced antimicrobial 
activity of TZ photoproducts against Gram‑positive bacteria. This was higher than ciprofloxacin effects 
for methicillin‑ and ciprofloxacin‑resistant Staphylococcus aureus. Molecular docking showed the 
Penicillin‑binding proteins PBP3 and PBP2a inhibition by sulforidazine as a possible mechanism of 
action against Staphylococcus aureus and MRSA strains, respectively. Irradiated TZ reveals possible 
advantages in the treatment of infectious diseases produced by antibiotic‑resistant Gram‑positive 
bacteria. TZ repurposing and its photoproducts, obtained by laser irradiation, show accelerated and 
low‑costs of development if compared to chemical synthesis.
Antimicrobial resistance is an increasing major risk to population health threatening our ability to fight infectious 
diseases. Nowadays, due to this already worldwide problem, drug discovery for treatment of such infections is 
approached with increasing attention. New low-cost drugs are needed, that are conceived for higher efficacy 
treatment and are suitable to be faster introduced in production phase. There are several approaches currently 
used in drug  discovery1–3 that can help pharmaceutical progress, one of them being drug  repurposing1–3 which 
basically consists of using drugs designed and approved to treat other diseases than their initial target. This is the 
case of phenothiazines in fighting infectious diseases acquired by multiple drug resistance (MDR) mechanisms. 
So, several groups have investigated the possibility of using thioridazine (TZ) as an antimicrobial agent. Rad-
hakrishnan et al. observed that TZ presents antimicrobial activity against 316 Gram-positive and Gram-negative 
bacterial  strains4. Costa et al. demonstrated that TZ can reduce the minimum inhibitory concentration (MIC) 
of ciprofloxacin (CIP) in Staphylococcus aureus (S. aureus) strains resistant to it by increased efflux, indicating a 
TZ role as an efflux  inhibitor5, as is the case also for Proteus mirabilis6. Thanacoody mentioned that TZ inactive 
metabolites or its enantiomers may have a future in development of antimicrobial drugs efficient in challenging 
infectious  diseases7. Moreover, other groups considered using TZ as anti-tuberculosis8,9, anti-inflammatory10, 
or anti-tumoral11 drug. Therefore, TZ could be considered a multi-purpose drug that could be repurposed as 
an antimicrobial agent.
Our study is focused on TZ repurposing from an anti-psychosis drug to an antimicrobial one, by irradiating 
it with 266 nm pulsed laser radiation to obtain an enhanced antimicrobial effect against multiple drug-resistant 
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(MDR) bacteria. We characterized irradiated TZ to evidence its photodegradation and generation of photoprod-
ucts. Drug-likeness of the suggested photoproducts was evaluated by applying drug-like rules such as Lipinski’s 
rule of five and Veber bioavailability rule. Possible mechanisms of action of TZ and its photoproducts were 
identified using several molecular docking models on three membrane proteins involved in S. aureus/MRSA 
cell wall biosynthesis and cell division.
Results
Antimicrobial activity of irradiated TZ. The screening for the optimal irradiation time that promotes 
the highest antimicrobial activity by irradiated TZ was performed against some of the most frequent pathogens 
found in hospital-acquired  infections12,13.
MIC values of unirradiated and irradiated TZ and of CIP against Gram-positive bacteria are presented in 
Table 1. Irradiated TZ had an enhanced antimicrobial activity against all Gram-positive tested strains. In par-
ticular, TZ irradiated 120 min showed consistently the best antimicrobial effect across all tested strains, showing 
MIC values four-fold to 16-fold lower than for unirradiated TZ. This enhanced antimicrobial activity was more 
pronounced for S. aureus, including the ciprofloxacin-resistant strains, due to increased efflux (S. aureus ATCC 
25923 EtBr) or mutations in the target proteins (S. aureus SM1).
For Gram-negative bacteria, irradiated TZ had no enhanced antimicrobial effect when compared to unirradi-
ated TZ. MIC values for unirradiated and irradiated TZ were 100 mg/L for E. coli ATCC 25922, 256 mg/L and 
for Salmonella enterica serotype Enteritidis NCTC 13349, and > 256 mg/L for Klebsiella aerogenes ATCC 15038.
As for the mechanisms of action against bacteria, they are not completely understood for TZ that affects, 
at subinhibitory concentrations, the replication of S. aureus and causes ultrastructural changes on the cell 
 envelope14, by intercalating in the cell membrane and interfering in the cell wall biosynthesis  pathway15,16. It 
can also inhibit S. aureus bacterial efflux  pumps17. Consequently, two of the above-mentioned mechanisms, the 
effect on efflux and the effect on membrane proteins, were further evaluated.
Efflux inhibitory activity of irradiated TZ. An inhibitor of efflux pump activity is defined by its abil-
ity to reverse or reduce the efflux-mediated resistance of a pathogen to a substrate, potentially an effluxable 
 antibiotic18. This inhibitory effect is commonly characterized by the capacity of the agent to reduce the MIC of 
an antibiotic by, at least, four-fold19. Therefore, the capacity of irradiated TZ to reduce MIC’s of ciprofloxacin 
was evaluated for two pairs of S. aureus and S. epidermidis strains comprising a parental and an EtBr-adapted 
derivative that overexpress the efflux pump gene norA, associated with CIP  resistance20,21. The resulting data (see 
Table S1 in Supplementary Data) showed only a minor effect (two-fold reduction) of unirradiated TZ on MIC 
of ciprofloxacin against S. aureus ATCC 25923_EtBr strain, whereas irradiated TZ solutions did not reverse or 
reduce the ciprofloxacin MIC’s of the tested strains, suggesting that the photoproducts of TZ irradiation are not 
efflux inhibitors (see Table S1 in Supplementary Data).
Characterization of irradiated TZ solutions. In order to identify the photoproducts, samples’ char-
acterization was performed by UV–Vis and FTIR absorbance spectroscopy, thin layer chromatography (TLC), 
laser-induced fluorescence (LIF) and dynamic surface tension measurements.
UV–Vis absorption analysis. The UV–Vis absorption spectra of unirradiated and 1–240 min irradiated TZ are 
given in Fig. 1a, where two absorption bands with peaks at 262 nm and 315 nm for unirradiated TZ are shown. 
The main peak at 262 nm is due to n → π * transition and the secondary at 315 nm to π → π * transition and to 
the Sulphur lone-electron pair from phenothiazine  ring22. During 240 min irradiation, UV–Vis absorption spec-
tra suffered hypochromic, hypsochromic, and bathochromic shifts when compared to unirradiated TZ (Fig. 1b 
and c).
Table 1.  MIC values of unirradiated and irradiated TZ and CIP against Gram-positive pathogens. Note: Bold-
type values evidence the shortest irradiation times needed to obtain the best antimicrobial effect.
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Thus, the absorbance intensity of 262 nm band presented a hypochromic shift of 45% by the end of irradiation 
(Fig. 1c). This effect was accompanied by a hypsochromic shift of 2 nm by the end of 240 min TZ irradiation 
(Fig. 1b). The 315 nm band shows a 4 nm bathochromic shift by the end of 30 min irradiation, after which its 
shape becomes broader.
LIF analysis. LIF spectra obtained during irradiation of 2 mg/ml TZ solution up to 240 min are characterized 
by a single band with a peak at 504 nm (Fig. 2a). Fluorescence intensity increases in the first minute of irradia-
tion and decreases afterwards (Fig. 2c). The peak intensity undergoes a 20 nm bathochromic shift by the end of 
irradiation time, suggesting formation of photoproducts (Fig. 2b).
LIF spectrum intensity does not depend on the N-10 position substituent but it is influenced by changes of 
the substituent at position  223. Hypsochromic shifts of 504 nm peak suggest structural changes of TZ molecule 
only in the case of substituents within phenothiazine ring.
Factors that can influence LIF spectrum are pH and irradiation time. The pH decrease during irradiation 
affects molecular reconfiguration that occurs after protonation of fluorophore’s electron  cloud23. In this respect, 
pH decreases during irradiation from 5.47 (unirradiated TZ) to 3 (240 min irradiated solution).
FTIR analysis. The samples were investigated by FTIR to identify the vibrations that correspond to various 
molecular bonds. IR spectra of unirradiated, 120 min irradiated, and 240 min irradiated TZ are shown in Fig. 3.
The band at 1405 cm-1 of unirradiated TZ, attributed to the deformation vibration of C-H bond ( \/N− CH3 ), 
was no longer found in 120 min and 240 min irradiated TZ spectrum suggesting the cleavage of N −CH3 bond, 
characteristic to TZ-N-desmethyl photoproduct.
In addition, the decrease in intensity and the change of the shapes of bands in 1354–1266 cm-1 range, are 
attributed to symmetrical stretching vibration of the S − C bond from S −CH3, suggesting that alternation of S −
CH3 bond could be due to addition of Oxygen atom to Sulphur atom forming mesoridazine and/or sulforidazine, 
which are two TZ  metabolites24.
Figure 1.  (a) UV–Vis absorption spectra of unirradiated and 1–240 min irradiated TZ water solutions (dilution 
0.2 mg/mL) in the 200–400 nm spectral range. Inset represents a close-up of the 280–400 nm range. (b) Peak 
wavelength behavior during irradiation. (c) Absorbance intensity behavior during irradiation.
Figure 2.  (a) LIF spectra of 2 mg/ml TZ solution irradiated up to 240 min. (b) Peak wavelength behavior 
during irradiation. (c) LIF intensity behavior during irradiation.
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The molecular structure of TZ and its proposed photoproducts are shown in Table 2. The band at 1050 cm-1 
of 120 min and 240 min irradiated TZ was attributed to stretching vibration of S = O bond, and indicated gen-
eration of oxidative forms. During irradiation, TZ was transformed into mesoridazine (TZ-2-sulfoxide), which 
undergoes further 2-oxidation to sulforidazine (TZ-2-sulphone).
TZ could also undergo 5-oxidation to the ring sulfoxide (TZ-5-sulfoxide)24. In irradiated TZ IR spectrum, 
disappearance of bands at 1405 cm-1 and 1388 cm-1 (O− H deformation vibration) and appearance of a new one 
at 1385 cm-1 (C− O stretching vibration from a phenol group) suggest the attachment of a phenol group to TZ 
molecule.
Surface tension analysis. The surface tension reflects a physicochemical property of a liquid that is often dis-
regarded in pharmaceutical  research25. More, adsorption, chemical activity, bioavailability or dissolution of a 
drug depends on its surface tension, making this technique to have a large influence in the development of new 
 drugs26. Liquid/air interface surface tension (ST) measurements were performed in order to evidence surface-
active photoproducts generated during irradiation of TZ with 266 nm beam, which are adsorbed at water/air 
 interface27. The equilibrium value for all samples was at  103 s.
The ST decreases with prolonged exposure time (TZ unirradiated, 55.93 mN/m and TZ irradiated 240 min, 
53.44 mN/m) and consequently, it can be stated that during irradiation, amphiphilic photoproducts were gen-
erated, followed by their migration to liquid/air interface. More, due to the lower ST when compared to that of 
water (72 mN/m) the solutions could be used in drug delivery systems without additional surfactants.
TLC analysis. The qualitative analysis of photoproducts can be achieved by analyzing the TLC plates at 254 nm 
(Fig. 4). Each column from the plate corresponds to a specific irradiation time; the first column represents the 
unirradiated sample, followed by the irradiated samples for 1, 15, 30, 60, 120, 180, or 240 min (from left to right). 
Most photoproducts visualized at 254 nm are more polar than TZ, their polarity increasing from top to bottom. 
The most polar photoproducts are found at the start line (dotted line) starting with 15 min irradiation time.
For TZ, a decrease in intensity is observed as well as a smaller spot diameter, suggesting the photodegradation 
of parental compound during irradiation.
Figure 3.  FTIR spectra of unirradiated TZ and 120 min and 240 min irradiated TZ.
Table 2.  The molecular structure of TZ and the identified photoproducts.
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TLC plate image was investigated with proper analysis software. Retention factor is defined as the distance 
travelled by compound divided by the distance travelled by mobile phase. Thus, for TZ, Rf value was 0.75, fol-
lowed by photoproducts or classes of photoproducts with 0.82, 0.64, 0.58, 0.5, 0.4, 0.3, 0.21, 0.12, and 0.006. 
For each photoproduct at each irradiation time, the relative volume was extracted and plotted against exposure 
times (Fig. 5a,b).
The volume, calculated with the same software, resulted from summing-up the difference between estimated 
background and noise filtered input image within each marked region. The filtering level is based on the noise 
level measured during plate analysis. The relative volume resulted from comparing the values of photoproducts 
spots with that of unirradiated TZ, which was considered as 100%.
The relative volume of the parental compound decreases during irradiation, being almost totally photo-
degraded after 240 min irradiation. Time evolution of the less polar than TZ photoproducts shows a maximum 
relative volume, for 30 min exposure, of 2.45%. The major compound for 120 min has Rf = 0.4, with relative 
volume of 18%, followed by TZ (16.7%). Relative volume of photoproducts does not exhibit a linear time evolu-
tion; the values decrease or increase with increased UV exposure duration. TZ-N-desmethyl was identified in 
TLC as the one with higher Rf, namely 0.8528.
Drug‑likeness evaluation of photoproducts. For a compound to be administrated orally it is mandatory to obey 
drug-like rules which help to remove the compounds that do not represent a promise candidate as a  drug29,30.
Figure 4.  TLC plate of unirradiated and irradiated TZ visualized at 254 nm. Legend: Rf—retention factor.
Figure 5.  The evolution of TZ and its photoproducts relative volumes, extracted from TLC plate via proper/
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Molecular descriptors partition coefficient octanol/water  (LogP(o/w), number of H-bond acceptors (HBA), 
H-bond donors (HBD), molecular weight (MW),Topological Polar Surface Area Å2 (TPSA) and the number of 
rotatable bonds (N_rotB) of photoproducts were predicted using a specific  platform31 and are given in Table 3.
The results suggest that all photoproducts respect Lipinski’s rule of five. More, Veber rule validation indicated 
that photoproducts presented a good oral bioavailability (Table 3).
Molecular docking. It has been reported that TZ interferes with cell wall  biosynthesis26. In addition, Thorsing 
et al. showed that TZ interferes with the peptidoglycan biosynthesis before the transpeptidation step by  PBPs15 
and Klitgaard et al. demonstrated that the combination of oxacillin and TZ reduced the protein level of PBP2a 
in  MRSA32.
Thus, to identify the possible mechanisms of action of TZ and its photoproducts, several molecular docking 
models were applied, using various proteins that participate in the biosynthesis of S. aureus/MRSA cell wall: 
two Penicillin-binding proteins (PBP2a–in MRSA strains, PDB code:  5M1833 and PBP3, PDB code:  3VSL34) and 
Filamentous temperature sensitive A (FtsA). PBPs’ catalyze the transglycosylation (polymerization) and trans-
peptidation (cross-link) of glycans that occurs on external surface of cytoplasmatic  membrane35. In MRSA strains, 
the additional PBP2a can proceed with the transpeptidation step in the presence of beta-lactam  antibiotics36. 
FtsA is involved in cellular division, in a specific initial phase of  cytokinesis37. In S. aureus, FtsA regulates GTPase 
activity of FtsZ (protein, that bring together to form a ring-like structure that allows daughter cells separation 
in bacterial cell division)38.
Predicted binding affinity of a compound is represented by the inhibitory constant  (Ki). A low  Ki value 
is correlated with a high biological activity  (pKi). For a better data analysis,  Ki values (expressed as M) were 





 . It was used as threshold  pKi = 4 or lower, 
to define a compound with no biological activity (Table 4).
Sulforidazine and mesoridazine were the compounds with the predicted highest biological activity on both 
PBP3 and PBP2a membrane proteins.  PKi values are higher than that of TZ. For FtsA, sulforidazine present the 
highest biological activity  (pKi = 6.5) (Table 4).
Table 3.  Drug-likeness of photoproducts predicted using Lipinski’s rule of five and Veber’s rule.





Mesoridazine 386.57 2 0 4.09 68.06 4 No No
Sulforidazine 402.57 3 0 4.13 74.30 4 No No
Thioridazine-5-sul-
foxide 386.57 2 0 4.12 68.06 4 No No
Thioridazine
N-desmethyl 370.57 1 0 5.03 57.08 4 No 1
Table 4.  Lowest binding energy (BE), predicted  Ki and  pKi for TZ and its photoproducts interaction with S. 
aureus proteins involved in cell wall biosynthesis or cell division.
Protein PBP2a
Photoproduct Thioridazine Mesoridazine Sulforidazine Thioridazine-5-sulfoxide
Thioridazine
N-desmethyl
Lowest BE (kcal/mol) − 7 − 8.6 − 8.3 − 7.3 − 6.9
Predicted  Ki (nM) 6500 474 746.8 4100 7400
Predicted  pKi 5.1 6.3 6.1 5.3 5.1
Protein PBP3
Photoproduct Thioridazine Mesoridazine Sulforidazine Thioridazine-5-sulfoxide
Thioridazine
N-desmethyl
Lowest BE (kcal/mol) − 7.1 − 9.0 − 9.2 − 8.2 − 7.5
Predicted  Ki (nM) 5470 248.46 171.3 939.9 2900
Predicted  pKi 5.2 6.6 6.7 6 5.5
Protein FtsA
Photoproduct Thioridazine Mesoridazine Sulforidazine Thioridazine-5-sulfoxide
Thioridazine
N-desmethyl
Lowest BE (kcal/mol) − 6.8 − 6.6 − 8.9 − 6.4 − 6.3
Predicted  Ki (nM) 8850 12770 286.5 18000 20100
Predicted  pKi 5 4.8 6.5 4.7 4.6
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Discussion
Developing new antimicrobial agents by the repurposing of current non-antibiotics could have a major benefit in 
allowing the extended reuse of existing medicines. The modification of medicine’s molecular structures through 
laser radiation represents a new approach in chemistry, biology, and pharmacology. The generated photoproducts 
and their concentrations can be controlled through irradiation process, by choosing the proper laser wavelength, 
irradiation time and dose.
Our study involved TZ exposure to 266 nm pulsed laser radiation in order to obtain compounds with better 
antimicrobial activity than CIP. The results presented in this study suggest that this approach helps in develop-
ing antimicrobial agents that are able to overcome spreading of MDR bacteria both in hospitals and public area. 
More, this irradiation method could help in personalized medicine, where for each type of bacterial infection the 
customized treatment could be performed in to obtain the best outcome. Similarly, in the case of a multiple-strain 
infection our method presents encouraging results. The multiple-strain infection is usually underestimated and 
it represents 21.7% of infections in humans, affecting the immune response of the host and decreases the treat-
ment  efficiency39. Taking this into consideration, the data presented in this paper prove promising antimicrobial 
activity against a panel of Gram-positive bacteria of 120 min irradiated TZ with a 266 nm laser beam, where the 
best MIC was observed for the entire strains.
Interesting enough, for the CIP-resistant strain S. aureus SM1, 120 min irradiated TZ showed an enhanced 
antimicrobial activity when compared to CIP; the MIC of 120 min irradiated TZ was of 3.12 mg/L (8.4 µM), 
whereas the MIC of CIP was 256 mg/L (0.77 mM). The same enhanced antimicrobial activity was detected for 
60 min irradiated TZ against S. epidermidis ATCC12228_EtBr. These results are encouraging and further assays 
on strains resistant to antibiotics should be considered.
In addition, the toxic side-effects of TZ are well known when it is administrated in long-term psychosis 
 treatment40, but in the case of bacterial infection where a shorter course of treatment is needed, thus less toxic-
ity, TZ should be taken into consideration. As for the photoproducts resulted during TZ irradiation, it is hard 
to predict their individual toxicity. The safety issues of irradiated TZ do not represent the purpose of this study. 
We cannot predict the degree of antimicrobial activity of the mixture of photoproducts against a real infection 
due to the complex pharmacokinetics of the implied processes. Thus, extended in vitro cell-based models for 
cytotoxicity screening and in vivo studies, which have to involve experimental infection models, are necessary 
in order to have an indicator of potential adverse effect on cells.
As for the mechanisms that can be attributed to TZ antimicrobial activity, they are not completely under-
stood. For example, TZ can inhibit, at subinhibitory concentration, the replication of S. aureus MRSA and 
causes ultrastructural changes in the structure of cell  envelope14. Also, it can inhibit bacterial efflux pumps of 
the above-mentioned  pathogen14. Due to these reasons, TZ may act as β-lactam antibiotics by inhibiting the 
membrane-bound enzymes. Additionally, in the case of enterococci, TZ antimicrobial activity is not related to 
the multidrug resistance mediated by the P-glycoprotein41.
The characterization of irradiated TZ solutions showed that all the changes to the initial UV–Vis and LIF spec-
tra suggested photo-degradation of parent compound, TZ, resulting in the formation of new reaction products 
by adding functional groups to its chemical structure. The UV–Vis absorption spectra evidenced hypochromic, 
hypsochromic, and bathochromic shifts when compared with that of the unirradiated TZ. Similarly, hypsoch-
romic shifts in LIF spectra suggest structural changes of TZ molecule only in the case of the substituents at the 
phenothiazine ring.
As for time-stability of the aqueous unirradiated and irradiated TZ solution investigated via UV–Vis spec-
troscopy, all irradiated TZ solutions stabilize after 24 h, except one min irradiated TZ that was stable even after 
48 h. Both 180 min and 240 min irradiated TZ were stable for 1 week. TZ solutions irradiated up to 1, 15, 30, 
and 60 min were stable 2 weeks and unirradiated TZ was stable for 3 weeks. During the first 24–48 h after irra-
diation, new transient species are evidenced in UV–Vis spectra like those responsible for the peaks at 454 and 
486 nm in the solution irradiated 1 and 15 min, and at 637 and 882 nm in the solution irradiated 1–120 min42.
The surface tension decreased as the exposure time to 266 nm laser beam increased, stating that, during 
irradiation, amphiphilic photoproducts were generated and that solutions could be used in drug delivery systems 
without additional surfactants.
The qualitative and quantitative analysis of the photoproducts generated from 266 nm irradiation of TZ was 
performed by analyzing the TLC plates at 254 nm. The relative volume analysis of the photoproducts did not 
exhibit a linear evolution in time, the relative volumes decreasing or increasing with increased UV exposure 
duration.
Therefore, the UV–Vis absorbance, FTIR, LIF, TLC and dynamic ST measurements suggested the generation 
of TZ-N-desmethyl, mesoridazine, TZ-5-sulfoxide, and sulforidazine. More, studies regarding the identification 
and separation of photoproducts by LC–MS may be useful in elucidating the responsible compounds for the 
enhanced antimicrobial activity when compound with the parental drug.
As for the mechanisms of action of the irradiated solutions, the predicted  pKi values indicate higher biological 
activity for TZ photoproducts mesoridazine and sulforidazine, than TZ, confirming the experimental results 
that irradiated TZ present higher inhibitory effect than non-irradiated TZ. The highest  pKi value was obtained 
for sulforidazine in interaction with PBP3. The protein binding site was identified in PDB, and was recognized 
by specific amino acid residues (Fig. 6). S. aureus PBP3 has 20 amino acids residues in ligand pocket  chain43. TZ 
was in close contact with to 8 amino acids residues fromPBP3 protein ligand pocket (Ser 392, Thr 603, Tyr 605, 
Val 606, Thr 619, Thr 621, Val 658, Pro 660) and sulphoridazine to 6 amino acids residues (Ser 448, Thr 603, 
Thr 619, Gly 620, Thr 621 and Pro 660). TZ present one atom in H-bond with Leu 663 amino acid (Fig. 6a) and 
sulforidazine presents 2 atoms in H-bonds with amino acids from protein ligand pocket (Fig. 6b) dotted line 
H-bound interaction between amino acids Thr 603 Thr 621 and Ser 634 surrounded with blue.
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These proteins catalyze the transpeptidation or cross-link that occurs on the external surface of cytoplas-
matic membrane. The mechanism of action of β-lactam antibiotics is inhibition of  PBPs35. The tested proteins 
were: (i) PBP2a from MRSA that replaces PBP2 TPase function and presents uncommon low affinity to all 
β-lactam  antibiotics44, except  5th generation cephalosporins (ii) PBP3, whose inhibition affects cell segregation 
after  division45, and (iii) FtsA, a protein important in cellular division, found in S. aureus. Due to the high biologi-
cal activity of TZ photoproducts on both PBP2a and PBP3 receptors, it can be said that the possible mechanism 
of action of those photoproducts may due to the inhibitory effect on PBP2a and PBP3 membrane receptors.
This study aims to provide in silico and in vitro evidence on the possible therapeutic relevance of irradiated 
TZ against Gram-positive bacteria infections, to be further translated into clinical research. Irradiated TZ samples 
can be obtained by using a laser radiation source in accordance with the protocol introduced in this work. This 
would assure a shorter time to obtain active antibacterial agents than current used approaches in drug discovery, 
involving lower costs. The irradiated TZ solutions can be applied in the treatment of patients who develop com-
munity/health-care associated infections, but they are designed particularly for MDR Gram-positive bacterial 
cutaneous infections for which therapies are lacking. The fastest way to achieve translational value is topical 
administration, where irradiated TZ solutions can be incorporated in hydrogel to treat wounds infected with 
Gram-positive bacteria; this would limit toxicity and optimize therapeutic action.
Figure 6.  Docking simulations on MRSA PBP3 chain A ligand pocket for TZ and sulphoridazine, amino acid 
residues presented are at a VDW scaling factor 1.00 (atoms closer than distance = atom1 vdw + atom2 vdw) 
(a) TZ close to ligand pocket dotted green line H-bound: interaction between TZ and Leu 663 amino acid. (b) 
Sulforidazine in ligand pocket, dotted green line H-bound: interaction between sulforidazine and amino acids 
Thr 621, Ser 634 and Thr 603.
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The procedure to expose TZ to laser radiation and repurpose for therapeutic use of its derivatives needs 
further studies to cover standard acceptance steps, such as: (i) statistically evaluate the irradiated solution stabil-
ity based on the conclusions drawn from this work (ii) expand the tests on bacteria that acquired resistance to 
treatment and are infecting patients in hospitals and in communities; (iii) apply currently on animal models of 
infection to test its efficacy in vivo (iv) finally develop ethically randomized controlled clinical studies to assess 
the applicability against a larger list of MDR Gram-positive bacteria infections in humans.
In conclusion, controlled laser irradiation of non-antibiotic drugs has the benefit of identifying possible 
pharmacological compounds with enhanced antimicrobial properties when compared to antibiotics, in order to 
overcome MDR acquired by bacteria, allowing to save time and resources. We observed an enhanced antimicro-
bial activity of TZ photoproducts against Gram-positive bacteria. This was higher than CIP action on methicil-
lin- and ciprofloxacin- resistant Staphylococcus aureus. The drug-likeness and bioavailability test identified all 
photoproducts as drug-like compounds. More, molecular docking assays on S. aureus/MRSA membrane proteins 
showed that the most possible inhibitory effect of irradiated TZ solution is achieved by blocking the activity of 
PBP3 and PBP2a by sulforidazine and mesoridazine.
Methods
Chemicals. Thioridazine hydrochloride (TZ) and Ciprofloxacin hydrochloride (CIP) were dissolved at 
2 mg/mL in ultrapure water, kept at 4 °C, and protected from environmental light.
Irradiation protocol. A 2 mL volume of TZ solutions were irradiated 1, 5, 15, 30, 60, 120, 180, or 240 min 
with 266 nm pulsed beam emitted by Nd:YAG laser (10 Hz, 6 ns FWHM) according to the irradiation protocol 
detailed in Alexandru et al. (2014)46.
Bacterial strains. The effect of TZ and its photoproducts was tested against a panel of reference Gram-
positive and Gram-negative bacteria, normally used as quality control in antimicrobial susceptibility testing. 
The panel also included laboratory-derived and clinical strains with defined antibiotic resistance patterns and 
mechanisms of resistance. The strains used are listed in Table 5.
Growth conditions. S. aureus and Enterococcus faecalis strains were grown in tryptone soya broth at 37 °C, 
with shaking or in tryptone soya agar. S. aureus ATCC 25923_EtBr and S. epidermidis ATCC 12228_EtBr were 
grown in TSB supplemented with 50 mg/L or 32 mg/L of EtBr, respectively. E. coli, Salmonella enterica and K. 
aerogenes strains were grown in Luria–Bertani agar at 37 °C.
Determination of minimum inhibitory concentrations. Minimum inhibitory concentrations (MICs) 
were determined in Mueller–Hinton broth by the two-fold broth microdilution  method54. Plates were incubated 
18 h at 37 °C, after which the MICs were registered as the minimum concentration of antimicrobial that inhib-
ited visual bacterial growth. The assays were made in triplicate. An enhanced antimicrobial effect was considered 
when MICs of irradiated TZ were, at least, four-fold lower than MICs of unirradiated TZ.
Table 5.  List of strains used in this study. Note on acronyms: MSSA: methicillin-susceptible S. aureus; MSSE: 
methicillin-susceptible S. epidermidis; MRSA: methicillin-resistant S. aureus; QRDR: quinolone-resistance 
determining region; QC: quality control.
Strains Main characteristics References
S. aureus ATCC 25923
MSSA; fully-susceptible




S. aureus ATCC25923 adapted to 50 mg/L of EtBr
Ciprofloxacin-resistant
Overexpresses norA efflux pump gene
Couto et al. (2008)20
S. epidermidis ATCC 12228 MSSE Costa et al. (2018)47
S. epidermidis ATCC12228_EtBr
S. epidermidis ATCC12228 adapted to 32 mg/L 
of EtBr
Ciprofloxacin-resistant





Mutations in GrlA QRDR: S80Y/E84G and GyrA 
QRDR: S84L
Costa et al. (2011, 2013, 2016)21,48,49
Enterococcus faecalis ATCC 29212 Recommended QC strain for antimicrobial susceptibility testing Kim et al. (2012)
50
E. coli ATCC 25922 Recommended QC strain for antimicrobial susceptibility testing Sjolund et al. (2009)
51
Salmonella enterica serotype Enteritidis NCTC 
13349 Reference strain Cerca et al. (2011)
52
Klebsiella aerogenes ATCC 15038 Reference strain Bornet et al. (2004)53
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Evaluation of efflux inhibitory activity. To test if unirradiated and irradiated TZ solutions could func-
tion as efflux inhibitors, their capacity to reduce CIP MICs was evaluated using two pairs of isogenic S. aureus 
and S. epidermidis strains comprising of a parental and a derivative strain overexpressing norA, an efflux pump 
gene associated with CIP resistance in both bacterial  species20,47.
MICs of ciprofloxacin were determined in presence of unirradiated and irradiated TZ by the two-fold broth 
microdilution method described above, with the addition of 10 µL of TZ (unirradiated or irradiated), at sub-
inhibitory concentrations (½ and ¼ MIC), prior to addition of the inoculum. Plates were incubated 18 h at 37 °C 
and the MICs were registered as the minimum concentration of agent with no visible bacterial growth. All assays 
were made in duplicate. An inhibitory effect is considered when the CIP MIC is reduced by, at least, four-fold 
when compared to the CIP MIC in the absence of the compound.
Characterization of irradiated samples. Absorption spectra were recorded between 200 and 400 nm. 
IR spectra were recorded using an FTIR spectrometer, between 3600 and 700 cm−1 at 4 cm−1 resolution and for 
an average of 32 scans. A volume of 20 μl of sample was dried on a KRS-5 (Thallium Bromo-Iodide) support. 
Each FTIR spectrum represented an average of 32 spectra.
Laser-induced fluorescence (LIF) signals were collected with an optical fiber positioned at 90° with respect 
to beam propagation direction, and recorded with a spectrograph (2.6 nm resolution), between 350 and 750 nm 
and represented the average of 100 spectra.
Dynamic surface tension measurements were performed using a drop and bubble shape tensiometer on single 
pendant drops having 20 μL volume. The measurements were made in triplicate.
A qualitative analysis of photoproducts was made by TLC with a normal phase  60F254 silica plate; the mobile 
phase was acetone:methanol:25% ammonia (50:50:1, v:v:v). One microliter of each sample was poured on TLC 
plate, which once developed was visualized at 254 nm and photographed with a standard camera. Photographs 
were analysed with selected software.
Molecular modelling. The 2D chemical structures format of TZ and its photoproducts were obtained using 
SMILES code from PubChem  database55. Geometry optimization of molecules was achieved in Discovery studio 
visualizer and saved as .mol2  format56. After optimization specific software was used to convert the molecules 
in .pdbqt  format57.
Drug‑likeness evaluation of photoproducts. The drug-like Lipinski and Veber rules were applied for 
photoproducts to identify promising candidates as possible drugs. Lipinski rule states that a compound which 
has a partition coefficient octanol/water  (LogP(o/w)) lower than 5, number of H-bond acceptors (HBA) lower 
than 10, H-bond donors (HBD) lower than 5 and molecular weight (MW) lower than 500 g/mol, respects the 
drug-like  rule58. Veber rule states that a compound with a Topological Polar Surface Area Å2 (TPSA) equal 
or lower than 140 and the number of rotatable bonds (N_rotB) equal or lower than 10, presents a good oral 
 bioavailability29.
Molecular docking. Specific  software59 were used to predict the mechanism of action of photoproducts 
regarding the inhibitory activity of TZ derivatives against S. aureus. Two Penicillin-binding proteins (PBPs) and 
Filamentous temperature sensitive A (FtsA) protein were used for prediction. S. aureus has 4 PBPs (PBP1-4); 
MRSA strains have an additional PBP, PBP2a, that determines methicillin  resistance60.The structure of proteins 
was taken from RCSB Protein Data Bank (PDB). It was predicted the binding energy (kcal/mol) of TZ and its 
photoproducts with: (i) PBP2a, PDB code:  5m1833; (ii) PBP3, PDB code:  3VSL34; (iii) FtsA, PDB code:  3WQU38. 
The grid-box was selected to contain only the active situs of the protein with grid points spacing at 0.375 Å. The 
energy barrier height was set at 1000 and the half-width at 5.00 Å. A total of 100 conformations were generated 
using the search parameter Genetic Algorithm. The output had been saved as Lamarckian.
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